Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

Antimicrob Agents Chemother. 1995 Jan;39(1):107-11. doi: 10.1128/AAC.39.1.107.

Abstract

PCR was used to amplify a 238-bp region from Helicobacter pylori which corresponded to the quinolone resistance-determining region in Escherichia coli. The gyrA gene of H. pylori was cloned and sequenced. An open reading frame of 2,478 nucleotides coded for a polypeptide of 826 amino acids with a calculated molecular mass of 92,508 Da. The amino acid sequence showed an overall 52% identity with other bacterial gyrA genes but was most closely related to the gyrA subunit of Campylobacter jejuni (76.5% identity). Sequencing of the amplification product from ciprofloxacin-resistant mutants of H. pylori revealed four classes of mutations with substitutions at amino acid 87 (Asn-->Lys), amino acid 88 (Ala-->Val), and amino acid 91 (Asp-->Gly, -->Asn, or -->Tyr) and a double substitution at amino acids 91 and 97 (Ala-->Val). Ciprofloxacin-susceptible strains of H. pylori could be transformed to ciprofloxacin resistance by using the amplified fragment from resistant strains as donor DNA. Of the 11 ciprofloxacin-resistant mutants examined, only one did not have an alteration within the quinolone resistance-determining region, suggesting that, in H. pylori, resistance to quinolones is primarily a result of alterations in gyrA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Ciprofloxacin / pharmacology*
  • DNA Gyrase
  • DNA Topoisomerases, Type II / drug effects*
  • Drug Resistance, Microbial
  • Gene Amplification
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / genetics*
  • Molecular Sequence Data
  • Mutation / drug effects
  • Polymerase Chain Reaction

Substances

  • Ciprofloxacin
  • DNA Gyrase
  • DNA Topoisomerases, Type II

Associated data

  • GENBANK/L29481